Bahrain Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Comparison of Remifentanil as a Sole Agent or in Combination With Midazolam Versus Fentanyl/Midazolam During Sedation for Colonoscopy
Condition:   Colonoscopy Interventions:   Drug: Midazolam, Fentanyl;   Drug: Midazolam, Remifentanil;   Drug: Remifentanil Sponsor:   King Hamad University Hospital, Bahrain Recruiting - verified February 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2015 Category: Research Source Type: clinical trials

Comparison of Remifentanil as a Sole Agent or in Combination With Midazolam Versus Fentanyl/Midazolam During Sedation for Colonoscopy
Condition:   Colonoscopy Interventions:   Drug: Midazolam, Fentanyl;   Drug: Midazolam, Remifentanil;   Drug: Remifentanil Sponsor:   King Hamad University Hospital, Bahrain Recruiting - verified January 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2015 Category: Research Source Type: clinical trials

Comparison of Remifentanil as a Sole Agent or in Combination With Midazolam Versus Fentanyl/Midazolam During Sedation for Colonoscopy
Condition:   Colonoscopy Interventions:   Drug: Midazolam, Fentanyl;   Drug: Midazolam, Remifentanil;   Drug: Remifentanil Sponsor:   King Hamad University Hospital, Bahrain Recruiting - verified February 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2015 Category: Research Source Type: clinical trials